CNO Financial Group, Inc.

Fundamentals6.0
Price Action7.0
News Sentiment0.0
AI Rating
6.0

Key Drivers

  • High leverage
  • Strong cash flow
  • Dividend support

AI
AI Summary

6.0

CNO's investment case has shifted from a steady dividend insurer to a cash-generating operator whose improving EPS, Medicare sales, and 12.2% operating ROE are being offset by extreme leverage and large unrealized bond losses, so upside now depends on several more quarters of clean execution and stable asset marks rather than just “good” earnings prints.

EarningsGrowth
Leverage
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • High leverage
  • Strong cash flow
  • Dividend support

CNO shows decent profitability and strong cash generation, but its highly leveraged balance sheet and narrowing interest coverage make the stock more dependent on steady operations than on financial flexibility.

LeverageRisk
CashFlowSupport

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Uptrend intact
  • Near resistance
  • Support holding

CNO's last month trend remains firmly upward, but it is stretched near $52.77 resistance with support around $50.8–$51.0, so a breakout is needed to extend the move.

uptrend
consolidation
Support Level: $50.8-$51.0
Resistance Level: $52.77

Quick rebound from $50.98 after a brief pullback signals buyers stepping in on weakness

Sentiment & News

0.0

Key News Insights:

  • 52-Week High
  • Valuation Watch
  • Sponsorship Extension

CNO Financial's June news centered on a sharp stock rally to 52-week highs, with investors debating whether the momentum can last amid a few corporate updates and dividend mentions.

Momentum

The news flow is likely supportive for near-term sentiment, but further upside will depend on CNO sustaining its momentum and proving valuation support